UZ7-22357-79689
3 vaccinations
1 coded response
7 check-ins
0 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 945 / CA
- Registered
- 2022-02-06
- Relationship
- Self
- Race
- Asian
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-05-26
Dose 1 — Pfizer-BioNTech
-
2021-06-26
Dose 2 — Pfizer-BioNTech
-
2022-02-05
Dose 3 — Pfizer-BioNTech
-
2022-02-06
Registered in v-safe
-
2022-02-06
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Fever · Joint pains, Muscle or body achesAdult check-in
-
2022-02-07
Survey response — days 1–6 daily, dose 3MedDRA: Axillary pain, Neck pain — Feeling: Poor · Site: Pain · Headache, Fatigue or tiredness · Be unable to work or attend schoolMedDRA releases: 2024-11
- 2022-02-12
- 2022-02-19
- 2022-03-07
- 2022-03-12
- 2022-03-23
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-05-26 | Pfizer-BioNTech | No |
| 2 | 2021-06-26 | Pfizer-BioNTech | No |
| 3 | 2022-02-05 | Pfizer-BioNTech | No |
Free text
None.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Axillary pain | · | · | ✓ |
| SRO | Neck pain | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release